X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with TTK HEALTHCARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. TTK HEALTHCARE FDC LTD./
TTK HEALTHCARE
 
P/E (TTM) x 29.1 50.0 58.2% View Chart
P/BV x 6.1 9.2 65.8% View Chart
Dividend Yield % 0.8 0.3 247.3%  

Financials

 FDC LTD.   TTK HEALTHCARE
EQUITY SHARE DATA
    FDC LTD.
Mar-14
TTK HEALTHCARE
Mar-14
FDC LTD./
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs144663 21.6%   
Low Rs79399 19.8%   
Sales per share (Unadj.) Rs47.6535.6 8.9%  
Earnings per share (Unadj.) Rs7.615.9 47.7%  
Cash flow per share (Unadj.) Rs9.020.0 45.0%  
Dividends per share (Unadj.) Rs2.254.00 56.3%  
Dividend yield (eoy) %2.00.8 268.6%  
Book value per share (Unadj.) Rs47.5137.6 34.5%  
Shares outstanding (eoy) m177.837.77 2,288.7%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.31.0 235.8%   
Avg P/E ratio x14.633.3 43.9%  
P/CF ratio (eoy) x12.326.5 46.5%  
Price / Book Value ratio x2.33.9 60.6%  
Dividend payout %29.625.1 117.9%   
Avg Mkt Cap Rs m19,7844,127 479.3%   
No. of employees `000NA1.7 0.0%   
Total wages/salary Rs m1,221607 201.2%   
Avg. sales/employee Rs ThNM2,436.7-  
Avg. wages/employee Rs ThNM355.2-  
Avg. net profit/employee Rs ThNM72.5-  
INCOME DATA
Net Sales Rs m8,4594,162 203.2%  
Other income Rs m39461 643.1%   
Total revenues Rs m8,8524,223 209.6%   
Gross profit Rs m2,070197 1,050.3%  
Depreciation Rs m24932 785.8%   
Interest Rs m3130 103.7%   
Profit before tax Rs m2,184197 1,110.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m60673 831.8%   
Profit after tax Rs m1,353124 1,092.1%  
Gross profit margin %24.54.7 516.8%  
Effective tax rate %27.737.0 74.9%   
Net profit margin %16.03.0 537.4%  
BALANCE SHEET DATA
Current assets Rs m4,3551,629 267.4%   
Current liabilities Rs m1,7921,058 169.4%   
Net working cap to sales %30.313.7 220.9%  
Current ratio x2.41.5 157.9%  
Inventory Days Days4430 149.3%  
Debtors Days Days2534 73.4%  
Net fixed assets Rs m3,025556 543.8%   
Share capital Rs m17978 229.9%   
"Free" reserves Rs m8,243878 938.5%   
Net worth Rs m8,4531,069 790.5%   
Long term debt Rs m11159 6.7%   
Total assets Rs m10,5572,399 440.0%  
Interest coverage x71.47.6 942.3%   
Debt to equity ratio x00.1 0.9%  
Sales to assets ratio x0.81.7 46.2%   
Return on assets %13.16.4 204.5%  
Return on equity %16.011.6 138.2%  
Return on capital %23.518.5 127.4%  
Exports to sales %13.30.8 1,683.5%   
Imports to sales %3.31.4 238.7%   
Exports (fob) Rs m1,12633 3,421.6%   
Imports (cif) Rs m28358 485.1%   
Fx inflow Rs m1,14633 3,483.6%   
Fx outflow Rs m35563 562.3%   
Net fx Rs m791-30 -2,610.8%   
CASH FLOW
From Operations Rs m1,485127 1,172.9%  
From Investments Rs m-620-146 424.3%  
From Financial Activity Rs m-75322 -3,436.1%  
Net Cashflow Rs m1133 4,512.0%  

Share Holding

Indian Promoters % 68.9 65.4 105.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 3.7 127.0%  
FIIs % 7.5 5.2 144.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 25.8 73.6%  
Shareholders   23,730 12,723 186.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   PLETHICO PHARMA  BIOCON LTD  UNICHEM LAB  ALKEM LABORATORIES  DIVIS LABORATORIES  

Compare FDC LTD. With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Strong Finish to the Week; Metal & Pharma Stocks Gain(Closing)

Indian share markets finished the trading session on a strong note amid firm Asian markets after comments from a Federal Reserve official eased worries about faster rate hikes in US.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Feb 23, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - ABBOTT INDIA COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS